Comparative assessment of low-molecular-weight heparins in cancer from the perspective of patient outcomes and survival

Patients with cancer are at high risk of developing venous thromboembolism (VTE), including deep venous thrombosis and pulmonary embolism. Compared to non-cancer patients, VTE in cancer is more frequently associated with clinical consequences, including recurrent VTE, bleeding, and an increase in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Falanga, Anna, Vignoli, Alfonso, Diani, Erika, Marchetti, Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417933/
https://www.ncbi.nlm.nih.gov/pubmed/22915978
http://dx.doi.org/10.2147/PROM.S10099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417933/
https://www.ncbi.nlm.nih.gov/pubmed/22915978
http://dx.doi.org/10.2147/PROM.S10099

Ejemplares similares